J. Goldman & Co »

Urogen Pharma shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $14M 597k 23.42

More positions owned by J. Goldman & Co

Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation (MSFT)
Honeywell International (HON)
Comcast Corp Cl A (CMCSA)
Western Union Company (WU)
Apple Call Option (AAPL)
Aramark Hldgs (ARMK)
Centuri Holdings Com Shs (CTRI)
Amazon (AMZN)
Gap (GAP)
eBay (EBAY)
Boeing Company (BA)
Sentinelone Cl A (S)
Verra Mobility Corp Cl A Com Stk (VRRM)

View all positions for J. Goldman & Co

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
Acorn Capital Advisors
SG Americas Securities
American Century Companies
Menora Mivtachim Holdings
Healthcare Of Ontario Pension Plan Trust Fund
Caption Management
MPM Oncology Impact Management
D. E. Shaw & Co

View all funds holding Urogen Pharma